Concepedia

Matthew Waldbrook

MW

Statistics

Publications

10

Citations

933

H-Index

10

Active since

2007

Affiliations

Xenon Pharmaceuticals (Canada)(Current)

Shanghai Zhangjiang Laboratory

University of British Columbia

Matthew Waldbrook is an author at Xenon Pharmaceuticals (Canada) specializing in pharmacology, sodium channel pharmacology, and molecular pharmacology.

Publications per year

2007–2024

10

Publications

10

An anti-infective peptide that selectively modulates the innate immune response

Monisha G. Scott, Edie Dullaghan, Neeloffer Mookherjee et al. · Nature Biotechnology · 2007 · 399 citations

, , +14

Synthetic Cationic Peptide IDR-1002 Provides Protection against Bacterial Infections through Chemokine Induction and Enhanced Leukocyte Recruitment

Anastasia Nijnik, Laurence Madera, Shuhua Ma et al. · The Journal of Immunology · 2010 · 207 citations · Full text

, , +17

Selective NaV1.7 Antagonists with Long Residence Time Show Improved Efficacy against Inflammatory and Neuropathic Pain

Girish Bankar, Samuel J. Goodchild, Sarah Howard et al. · Cell Reports · 2018 · 77 citations · Full text

, , +17

Discovery of Aryl Sulfonamides as Isoform-Selective Inhibitors of Na<sub>V</sub>1.7 with Efficacy in Rodent Pain Models

Thilo Focken, Shifeng Liu, Navjot Chahal et al. · ACS Medicinal Chemistry Letters · 2016 · 72 citations · Full text

, , +17

Discovery of Acyl-sulfonamide Na<sub>v</sub>1.7 Inhibitors GDC-0276 and GDC-0310

Brian S. Safina, Steven J. McKerrall, Shaoyi Sun et al. · Journal of Medicinal Chemistry · 2021 · 39 citations · Full text

, , +12

1–5 of 10